Home › Companies › AnaptysBio, Inc. › 2024-2025

AnaptysBio, Inc. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and AnaptysBio, Inc.’s Form 8-K, filed 2025-06-17 (Item 5.07 on EDGAR). Page generated 02 October 2026.

9Reported items
183Asset managers
1,397Fund votes
2025-06-17Meeting date

Proxy season: 2023-2024 2024-2025

Explore AnaptysBio, Inc. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by AnaptysBio, Inc.

These tallies are AnaptysBio, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-06-17 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

AnaptysBio, Inc. — official shareholder meeting results, meeting held 2025-06-17
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Elect Director: Rita Jain, M.D.	23,913,554	--	1,763,097	1,763,097	1,589,342	Majority: yes
Elect Director: John Orwin	21,616,016	--	4,060,635	4,060,635	1,589,342	Majority: yes
Elect Director: J. Anthony Ware, M.D.	21,035,965	--	4,640,686	4,640,686	1,589,342	Majority: yes
Proposal 2: Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025:	27,248,166	17,021	806	806	--	Majority: yes
Proposal 3: Non-binding, advisory approval of compensation paid to the Company's named executive officers:	17,781,545	6,590,193	1,304,913	1,304,913	1,589,342	Majority: yes
Proposal 4: Approval of the amendment and restatement of the Company's 2017 Equity Incentive Plan:	18,017,143	6,354,718	1,304,790	1,304,790	1,589,342	Majority: yes

Source: AnaptysBio, Inc., Form 8-K, filed with the SEC on 2025-06-17 — read the filing on EDGAR.

How asset managers voted at the AnaptysBio, Inc. 2024-2025 meeting

Each item below shows how the 183 asset managers that disclosed a AnaptysBio, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of AnaptysBio, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. To conduct a non-binding advisory vote on the compensation of our named executive officers as disclosed in the accompanying materials.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2025-06-17.

Combines 7 wordings of this item as funds reported it.

73% Majority: yes · of votes cast

FOR 73%AGAINST 27%

FOR: 17,781,545AGAINST: 6,590,193

AnaptysBio, Inc.’s own tally for this item (“Proposal 3: Non-binding, advisory approval of compensation paid to the Company's named executive officers:”): 17,781,545 for, 6,590,193 against, per its Form 8-K filed 2025-06-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 30,387,893 outstanding shares: 59% for, 22% against (80% of the company cast a for/against vote).

The 180 asset managers below cast 68% of the shares they voted on this item FOR (16,831,292 for, 8,007,118 against).

FOR 66%AGAINST 31%

FOR: 16,831,292 (65.6%)AGAINST: 8,007,118 (31.2%)0: 806,346 (3.1%)

Largest asset managers voting on “To conduct a non-binding advisory vote on the compensation of our named executive officers as disclosed in the” at AnaptysBio, Inc., 2024-2025
Asset manager	For	Against	Vote
EcoR1 Capital, LLC	7,880,094	0	For
First Light Asset Management, LLC	4,111,731	0	For
Point72	1,719,746	0	For
T. Rowe Price	0	1,213,537	Against
BlackRock	97,439	1,007,341	Against
Victory Capital	0	1,044,854	Against
Sofinnova Investments, Inc.	0	813,516	Against
Palo Alto Investors LP	0	0	0
Woodline Partners LP	760,770	0	For
Camber Capital Management LP	0	750,000	Against
Fidelity	0	727,769	Against
State Street	463,880	2,521	For
5AM Venture Management, LLC	357,733	0	For
FRANKLIN ADVISERS INC	0	354,370	Against
Charles Schwab	0	308,580	Against
Madison Avenue Partners, LP	291,788	0	For
Vanguard	276,556	1,010	For
Bridge Builder Trust	0	241,610	Against
Ensign Peak Advisors, Inc	215,454	0	For
Citadel	179,035	0	For
Northern Trust	132,684	4,299	For
FRANKLIN STRATEGIC SERIES	0	128,979	Against
Opaleye Management Inc.	98,674	0	For
Exome Asset Management LLC	97,696	0	For
Nuveen	0	96,998	Against

Showing the 25 largest of 180 asset managers. See all 180 in the interactive database.

2. Non-binding advisory vote on the frequency of holding future advisory votes regarding named executive officer compensation.

SECTION 14A SAY-ON-PAY VOTES

Meeting held 2025-06-17.

Combines 3 wordings of this item as funds reported it.

99.8% fund support · no official result

FOR 24%ONE YEAR 55.0%1 YEAR 16%

The 168 asset managers below cast 99.8% of the shares they voted on this item FOR (4,112,951 for, 6,159 against).

FOR: 4,112,951 (23.6%)AGAINST: 6,159 (0.0%)ONE YEAR: 9,588,944 (55.0%)1 YEAR: 2,715,309 (15.6%)0: 806,346 (4.6%)3 YEARS: 215,470 (1.2%)THREE YEARS: 2,819 (0.0%)1-YEAR: 214 (0.0%)

Largest asset managers voting on “Non-binding advisory vote on the frequency of holding future advisory votes regarding named executive officer ” at AnaptysBio, Inc., 2024-2025
Asset manager	For	Vote
First Light Asset Management, LLC	4,111,731	For
Point72	0	One Year
T. Rowe Price	0	One Year
BlackRock	0	1 Year
Victory Capital	0	One Year
Sofinnova Investments, Inc.	0	One Year
Palo Alto Investors LP	0	0
Woodline Partners LP	0	One Year
Camber Capital Management LP	0	One Year
Fidelity	0	One Year
State Street	0	One Year
5AM Venture Management, LLC	0	1 Year
FRANKLIN ADVISERS INC	0	One Year
Charles Schwab	0	1 Year
Madison Avenue Partners, LP	0	1 Year
Vanguard	0	One Year
Bridge Builder Trust	0	1 Year
Ensign Peak Advisors, Inc	0	3 Years
Citadel	0	One Year
Northern Trust	0	1 Year
FRANKLIN STRATEGIC SERIES	0	One Year
Nuveen	0	One Year
TIAA	0	One Year
Delaware/Macquarie	0	One Year
MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST	0	One Year

Showing the 25 largest of 168 asset managers. See all 168 in the interactive database.

3. TO APPROVE AN AMENDMENT TO OUR 2017 EQUITY INCENTIVE PLAN.

COMPENSATIONMajority of the votes cast: yes

Meeting held 2025-06-17.

Combines 2 wordings of this item as funds reported it.

74% Majority: yes · of votes cast

FOR 74%AGAINST 26%

FOR: 18,017,143AGAINST: 6,354,718

AnaptysBio, Inc.’s own tally for this item (“Proposal 4: Approval of the amendment and restatement of the Company's 2017 Equity Incentive Plan:”): 18,017,143 for, 6,354,718 against, per its Form 8-K filed 2025-06-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 30,387,893 outstanding shares: 59% for, 21% against (80% of the company cast a for/against vote).

The 50 asset managers below cast 84% of the shares they voted on this item FOR (12,574,522 for, 2,349,420 against).

FOR 84%AGAINST 16%

FOR: 12,574,522 (84.3%)AGAINST: 2,349,420 (15.7%)

Largest asset managers voting on “TO APPROVE AN AMENDMENT TO OUR 2017 EQUITY INCENTIVE PLAN.” at AnaptysBio, Inc., 2024-2025
Asset manager	For	Against	Vote
EcoR1 Capital, LLC	7,880,094	0	For
First Light Asset Management, LLC	4,111,731	0	For
BlackRock	554,358	0	For
T. Rowe Price	0	495,111	Against
Victory Capital	0	393,769	Against
Vanguard	0	246,836	Against
Bridge Builder Trust	4,180	237,430	Against
Fidelity	7,629	182,975	Against
Charles Schwab	0	154,290	Against
State Street	313	131,471	Against
FRANKLIN STRATEGIC SERIES	0	128,979	Against
TIAA	0	95,968	Against
Delaware/Macquarie	0	93,732	Against
Equitable	3,858	30,320	Against
Jackson National	0	33,320	Against
Northern Trust	0	18,214	Against
Lincoln Financial	0	15,600	Against
ProShares	0	11,284	Against
AIG/SunAmerica	0	11,042	Against
Federated Hermes	0	7,913	Against
ETFis Series Trust I	0	7,490	Against
ALPS ETF Trust	0	7,427	Against
Pacific Life	7,229	0	For
Brighthouse	0	6,034	Against
Direxion Shares ETF Trust	0	5,485	Against

Showing the 25 largest of 50 asset managers. See all 50 in the interactive database.

4. To elect three Class II directors, each to serve three-year terms through the third annual meeting of stockholders following this meeting and until a successor has been elected and qualified or until earlier resignation or removal: J. Anthony Ware, M.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-06-17.

Combines 2 wordings of this item as funds reported it.

82% Majority: yes · of votes cast

FOR 82%WITHHELD 18%

FOR: 21,035,965WITHHELD: 4,640,686

AnaptysBio, Inc.’s own tally for this item (“Elect Director: J. Anthony Ware, M.D.”): 21,035,965 for, 4,640,686 withheld, per its Form 8-K filed 2025-06-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 30,387,893 outstanding shares: 69% for, 15% withheld (84% of the company cast a for/withheld vote).

The 47 asset managers below cast 100% of the shares they voted on this item FOR (1,746,056 for, 0 against).

FOR 60%ABSTAIN 40%

FOR: 1,746,056 (59.6%)ABSTAIN: 1,183,352 (40.4%)

Largest asset managers voting on “To elect three Class II directors, each to serve three-year terms through the third annual meeting of stockhol” at AnaptysBio, Inc., 2024-2025
Asset manager	For	Abstain	Vote
BlackRock	554,358	0	For
T. Rowe Price	495,111	0	For
Victory Capital	0	393,769	Abstain
Vanguard	246,436	400	For
Bridge Builder Trust	4,180	237,430	Abstain
Fidelity	20,956	169,648	Abstain
Charles Schwab	154,290	0	For
State Street	131,614	170	For
FRANKLIN STRATEGIC SERIES	0	128,979	Abstain
TIAA	95,968	0	For
Delaware/Macquarie	0	93,732	Abstain
Equitable	3,858	30,320	Abstain
Jackson National	0	33,320	Abstain
Northern Trust	0	18,214	Abstain
Lincoln Financial	15,600	0	For
ProShares	0	11,284	Abstain
AIG/SunAmerica	0	11,042	Abstain
Federated Hermes	7,913	0	For
ETFis Series Trust I	0	7,490	Abstain
ALPS ETF Trust	0	7,427	Abstain
Pacific Life	7,229	0	For
Brighthouse	0	6,034	Abstain
Direxion Shares ETF Trust	0	5,485	Abstain
MASTER INVESTMENT PORTFOLIO	5,088	0	For
John Hancock	0	4,424	Abstain

Showing the 25 largest of 47 asset managers. See all 47 in the interactive database.

5. To elect three Class II directors, each to serve three-year terms through the third annual meeting of stockholders following this meeting and until a successor has been elected and qualified or until earlier resignation or removal: John Orwin

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-06-17.

Combines 2 wordings of this item as funds reported it.

84% Majority: yes · of votes cast

FOR 84%WITHHELD 16%

FOR: 21,616,016WITHHELD: 4,060,635

AnaptysBio, Inc.’s own tally for this item (“Elect Director: John Orwin”): 21,616,016 for, 4,060,635 withheld, per its Form 8-K filed 2025-06-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 30,387,893 outstanding shares: 71% for, 13% withheld (84% of the company cast a for/withheld vote).

The 47 asset managers below cast 100% of the shares they voted on this item FOR (1,905,216 for, 0 against).

FOR 65%ABSTAIN 35%

FOR: 1,905,216 (65.0%)ABSTAIN: 1,024,192 (35.0%)

Largest asset managers voting on “To elect three Class II directors, each to serve three-year terms through the third annual meeting of stockhol” at AnaptysBio, Inc., 2024-2025
Asset manager	For	Abstain	Vote
BlackRock	554,358	0	For
T. Rowe Price	495,111	0	For
Victory Capital	0	393,769	Abstain
Vanguard	246,436	400	For
Bridge Builder Trust	4,180	237,430	Abstain
Fidelity	20,956	169,648	Abstain
Charles Schwab	154,290	0	For
State Street	131,614	170	For
FRANKLIN STRATEGIC SERIES	128,979	0	For
TIAA	95,968	0	For
Delaware/Macquarie	0	93,732	Abstain
Equitable	3,858	30,320	Abstain
Jackson National	0	33,320	Abstain
Northern Trust	18,214	0	For
Lincoln Financial	15,600	0	For
ProShares	0	11,284	Abstain
AIG/SunAmerica	0	11,042	Abstain
Federated Hermes	7,913	0	For
ETFis Series Trust I	0	7,490	Abstain
ALPS ETF Trust	0	7,427	Abstain
Pacific Life	7,229	0	For
Brighthouse	0	6,034	Abstain
Direxion Shares ETF Trust	0	5,485	Abstain
MASTER INVESTMENT PORTFOLIO	5,088	0	For
John Hancock	0	4,424	Abstain

Showing the 25 largest of 47 asset managers. See all 47 in the interactive database.

6. To elect three Class II directors, each to serve three-year terms through the third annual meeting of stockholders following this meeting and until a successor has been elected and qualified or until earlier resignation or removal: Rita Jain, M.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-06-17.

Combines 2 wordings of this item as funds reported it.

93% Majority: yes · of votes cast

FOR 93%

FOR: 23,913,554WITHHELD: 1,763,097

AnaptysBio, Inc.’s own tally for this item (“Elect Director: Rita Jain, M.D.”): 23,913,554 for, 1,763,097 withheld, per its Form 8-K filed 2025-06-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 30,387,893 outstanding shares: 79% for, 6% withheld (84% of the company cast a for/withheld vote).

The 47 asset managers below cast 100% of the shares they voted on this item FOR (2,145,495 for, 0 against).

FOR 73%ABSTAIN 27%

FOR: 2,145,495 (73.2%)ABSTAIN: 783,913 (26.8%)

Largest asset managers voting on “To elect three Class II directors, each to serve three-year terms through the third annual meeting of stockhol” at AnaptysBio, Inc., 2024-2025
Asset manager	For	Abstain	Vote
BlackRock	1,110	553,248	Abstain
T. Rowe Price	495,111	0	For
Victory Capital	393,769	0	For
Vanguard	246,836	0	For
Bridge Builder Trust	237,430	4,180	For
Fidelity	13,827	176,777	Abstain
Charles Schwab	154,290	0	For
State Street	131,784	0	For
FRANKLIN STRATEGIC SERIES	128,979	0	For
TIAA	95,968	0	For
Delaware/Macquarie	93,732	0	For
Equitable	0	34,178	Abstain
Jackson National	33,320	0	For
Northern Trust	18,214	0	For
Lincoln Financial	15,600	0	For
ProShares	11,284	0	For
AIG/SunAmerica	11,042	0	For
Federated Hermes	0	7,913	Abstain
ETFis Series Trust I	7,490	0	For
ALPS ETF Trust	7,427	0	For
Pacific Life	0	7,229	Abstain
Brighthouse	6,034	0	For
Direxion Shares ETF Trust	5,485	0	For
MASTER INVESTMENT PORTFOLIO	5,088	0	For
John Hancock	4,424	0	For

Showing the 25 largest of 47 asset managers. See all 47 in the interactive database.

7. TO RATIFY THE APPOINTMENT OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2025.

AUDIT-RELATEDMajority of the votes cast: yes

Meeting held 2025-06-17.

99.9% Majority: yes · of votes cast

FOR 99.9%

FOR: 27,248,166AGAINST: 17,021

AnaptysBio, Inc.’s own tally for this item (“Proposal 2: Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025:”): 27,248,166 for, 17,021 against, per its Form 8-K filed 2025-06-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 30,387,893 outstanding shares: 90% for, 0.1% against (90% of the company cast a for/against vote).

The 47 asset managers below cast 99.9% of the shares they voted on this item FOR (2,929,054 for, 354 against).

FOR 99.9%

FOR: 2,929,054 (100.0%)AGAINST: 354 (0.0%)

Largest asset managers voting on “TO RATIFY THE APPOINTMENT OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR” at AnaptysBio, Inc., 2024-2025
Asset manager	For	Against	Vote
BlackRock	554,358	0	For
T. Rowe Price	495,111	0	For
Victory Capital	393,769	0	For
Vanguard	246,836	0	For
Bridge Builder Trust	241,610	0	For
Fidelity	190,604	0	For
Charles Schwab	154,290	0	For
State Street	131,776	8	For
FRANKLIN STRATEGIC SERIES	128,979	0	For
TIAA	95,968	0	For
Delaware/Macquarie	93,732	0	For
Equitable	34,178	0	For
Jackson National	33,320	0	For
Northern Trust	18,214	0	For
Lincoln Financial	15,600	0	For
ProShares	11,284	0	For
AIG/SunAmerica	11,042	0	For
Federated Hermes	7,913	0	For
ETFis Series Trust I	7,490	0	For
ALPS ETF Trust	7,427	0	For
Pacific Life	7,229	0	For
Brighthouse	6,034	0	For
Direxion Shares ETF Trust	5,485	0	For
MASTER INVESTMENT PORTFOLIO	5,088	0	For
John Hancock	4,424	0	For

Showing the 25 largest of 47 asset managers. See all 47 in the interactive database.

8. Advisory Vote on Say on Pay Frequency

SECTION 14A SAY-ON-PAY VOTESCOMPENSATION

Meeting held 2025-06-17.

— fund support · no official result

1 YEAR 89%11%

No shares were cast for or against this item by the managers below — every disclosed position was an abstention or was not voted.

1 YEAR: 75,528 (88.5%)ONE YEAR: 9,783 (11.5%)

Largest asset managers voting on “Advisory Vote on Say on Pay Frequency” at AnaptysBio, Inc., 2024-2025
Asset manager	For	Against	Abstain	Withheld	Vote
Granahan Investment Management, LLC	0	0	0	0	1 Year
JPMorgan	0	0	0	0	One Year
FORUM FUNDS II	0	0	0	0	1 Year
Coyle Financial Counsel LLC	0	0	0	0	1 Year

9. To conduct a non-binding advisory vote on the compensation of our named executive officers as disclosed in the accompanying materials.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2024-06-12 (outside the 2024-2025 season's 1 July to 30 June window; reported in this season's filings).

87% Majority: yes · of votes cast

FOR 87%13%

FOR: 19,874,097AGAINST: 2,954,956

AnaptysBio, Inc.’s own tally for this item (“Proposal 3: Non-binding, advisory approval of compensation paid to the Company's named executive officers:”): 19,874,097 for, 2,954,956 against, per its Form 8-K filed 2024-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 30,387,893 outstanding shares: 65% for, 10% against (75% of the company cast a for/against vote).

The 2 asset managers below cast 100% of the shares they voted on this item FOR (95 for, 0 against).

FOR 100%

FOR: 95 (100.0%)

Largest asset managers voting on “To conduct a non-binding advisory vote on the compensation of our named executive officers as disclosed in the” at AnaptysBio, Inc., 2024-2025
Asset manager	For	Against	Abstain	Withheld	Vote
COLDSTREAM CAPITAL MANAGEMENT INC	95	0	0	0	For
Echo45 Advisors LLC	0	0	0	0	--

Largest AnaptysBio, Inc. shareholders voting in 2024-2025

Ranked by the number of AnaptysBio, Inc. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 30,387,893 shares outstanding at the time of that meeting.

Top AnaptysBio, Inc. shareholders by shares voted, 2024-2025
#	Asset manager	% of shares outstanding
1	EcoR1 Capital, LLC	25.93%
2	First Light Asset Management, LLC	13.53%
3	Point72	5.66%
4	T. Rowe Price	3.99%
5	BlackRock	3.64%
6	Victory Capital	3.44%
7	Sofinnova Investments, Inc.	2.68%
8	Palo Alto Investors LP	2.65%
9	Woodline Partners LP	2.50%
10	Camber Capital Management LP	2.47%

Reported AnaptysBio, Inc. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

AnaptysBio, Inc. beneficial owners on record for the 2024-2025 proxy season
Holder	% outstanding	Disclosure
EcoR1 Capital LLC	25.93%	DEF14A
Oleg Nodelman	25.93%	DEF14A
First Light Asset Management, LLC	15.31%	13G
FMR LLC	9.45%	DEF14A
Point72	7.79%	13F
BlackRock	7.16%	13F
FMR (Fidelity)	6.27%	13F
Point72 Asset Management, L.P.	5.57%	DEF14A
James N. Topper	5.45%	13G
Vanguard Group	4.99%	13F

Percentages above are of 30,387,893 shares outstanding, as reported by AnaptysBio, Inc. on its Form 10-Q dated 2025-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from AnaptysBio, Inc.’s 10-Q dated 2025-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At AnaptysBio, Inc.'s shareholder meeting held 2025-06-17, in the 2024-2025 proxy season, 183 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,397 separate fund positions. Their filings are grouped here into 9 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To conduct a non-binding advisory vote on the compensation of our named executive officers as… — FOR was 73% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: AnaptysBio, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-06-17.

AnaptysBio, Inc. proxy season coverage: 2023-2024 · 2024-2025 (this page).